WO2009063962A1 - Fat emulsion containing medicinal agent, and process for production thereof - Google Patents
Fat emulsion containing medicinal agent, and process for production thereof Download PDFInfo
- Publication number
- WO2009063962A1 WO2009063962A1 PCT/JP2008/070736 JP2008070736W WO2009063962A1 WO 2009063962 A1 WO2009063962 A1 WO 2009063962A1 JP 2008070736 W JP2008070736 W JP 2008070736W WO 2009063962 A1 WO2009063962 A1 WO 2009063962A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fat
- oil
- medicinal agent
- agent
- emulsion containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
Abstract
The object is to provide: a fat emulsion containing a medicinal agent, which can be used as an injection preparation, an eye drop, a nose drop, an inhalation preparation or the like, and which has transparency and excellent stability; and a process for producing the fat emulsion. Specifically disclosed is a fat emulsion containing a medicinal agent, which comprises at least a poorly water-soluble medicinal agent, an oil-and-fat, an emulsifying agent and water, wherein the content of the oil-and-fat is 0.05 to 2 mg/mL, wherein the ratio of the medicinal agent to the oil-and-fat [(medicinal agent)/(oil-and-fat)] is 0.01 to 20 by weight (provided that the total amount of the medicinal agent and the oil-and-fat is up to 5 mg/mL), and wherein the ratio of the emulsifying agent to the oil-and-fat [(emulsifying agent)/(oil-and-fat)] is 1 to 300 by weight. Also specifically disclosed is a process for producing the fat emulsion, which comprises emulsifying the constituent components, wherein the content of the oil-and-fat is 0.05 to 2 mg/mL, wherein the ratio of the medicinal agent to the oil-and-fat [(medicinal agent)/(oil-and-fat)] is 0.01 to 20 by weight (provided that the total amount of the medicinal agent and the oil-and-fat is up to 5 mg/mL), and wherein the ratio of the emulsifying agent to the oil-and-fat [(emulsifying agent)/(oil-and-fat)] is 1 to 300 by weight.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009541177A JP5340954B2 (en) | 2007-11-16 | 2008-11-14 | Drug-containing fat emulsion and method for producing the same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007297879 | 2007-11-16 | ||
JP2007-297879 | 2007-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2009063962A1 true WO2009063962A1 (en) | 2009-05-22 |
Family
ID=40638808
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2008/070736 WO2009063962A1 (en) | 2007-11-16 | 2008-11-14 | Fat emulsion containing medicinal agent, and process for production thereof |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5340954B2 (en) |
WO (1) | WO2009063962A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010270023A (en) * | 2009-05-20 | 2010-12-02 | Techno Guard Kk | Nonaqueous composition containing adipose particle holding medicament, and method for producing the same |
FR2962044A1 (en) * | 2010-04-21 | 2012-01-06 | Horus Pharma | LACRYMIMETIC EMULSION |
JP2014001203A (en) * | 2012-05-23 | 2014-01-09 | Q P Corp | Method for increasing content of nonsteroidal anti-inflammatory agent in fat emulsion and pharmaceutical composition |
JP2014237722A (en) * | 2014-09-19 | 2014-12-18 | ロート製薬株式会社 | Ophthalmic composition for contact lens |
JP2017506671A (en) * | 2014-02-14 | 2017-03-09 | ホアン,ジンジュン | Composition of nanoemulsion delivery system |
CN106727308A (en) * | 2016-12-14 | 2017-05-31 | 广东药科大学 | A kind of dexamethasone lipid emulsion droplet ocular fluid and preparation method thereof |
CN107441044A (en) * | 2017-08-29 | 2017-12-08 | 辅必成(上海)医药科技有限公司 | A kind of nanometer fat emulsion |
US10413384B2 (en) | 2015-06-29 | 2019-09-17 | Kettenbach Gmbh & Co. Kg | Container for storing and dispensing at least one component and method therefor |
WO2020017571A1 (en) * | 2018-07-18 | 2020-01-23 | テイコク ファーマ ユーエスエー インコーポレーテッド | Flurbiprofen-axetil-containing fat emulsion and method for manufacturing same |
WO2020017578A1 (en) * | 2018-07-18 | 2020-01-23 | テクノガード株式会社 | Oxycam-based drug-containing injection agent |
CN112704674A (en) * | 2019-10-25 | 2021-04-27 | 北京远大九和药业有限公司 | Oral emulsion and its prepn and use |
US11103490B2 (en) | 2010-10-12 | 2021-08-31 | Chiesi Farmaceutici S.P.A. | Clevidipine emulsion formulations containing antimicrobial agents |
JP7456599B2 (en) | 2017-01-12 | 2024-03-27 | テクノガード株式会社 | Drug-containing fat emulsion and its manufacturing method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07505368A (en) * | 1992-03-26 | 1995-06-15 | ファーモス コーポレイション | Local and transdermal administration system using ultra-fine oil spheres |
JPH11332463A (en) * | 1998-05-28 | 1999-12-07 | Nof Corp | Oil-soluble matter-solubilized composition, its production and food/drink containing the same |
JP2000143542A (en) * | 1998-11-10 | 2000-05-23 | Wakamoto Pharmaceut Co Ltd | Sparingly soluble immunosuppressant-containing o/w emulsion pharmaceutical preparation |
JP2005225818A (en) * | 2004-02-13 | 2005-08-25 | Otsuka Pharmaceut Factory Inc | Medicinal composition of paclitaxel or docetaxel |
JP2007039430A (en) * | 2005-06-29 | 2007-02-15 | Mitsubishi Chemicals Corp | Particulate dispersion composition, method for producing the same and particulate substance and medicine |
JP2007525536A (en) * | 2004-03-01 | 2007-09-06 | エフゲニー パヴロヴィッチ ゲルマノフ | Perfluoro organic compound medical emulsion and its production |
-
2008
- 2008-11-14 JP JP2009541177A patent/JP5340954B2/en active Active
- 2008-11-14 WO PCT/JP2008/070736 patent/WO2009063962A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07505368A (en) * | 1992-03-26 | 1995-06-15 | ファーモス コーポレイション | Local and transdermal administration system using ultra-fine oil spheres |
JPH11332463A (en) * | 1998-05-28 | 1999-12-07 | Nof Corp | Oil-soluble matter-solubilized composition, its production and food/drink containing the same |
JP2000143542A (en) * | 1998-11-10 | 2000-05-23 | Wakamoto Pharmaceut Co Ltd | Sparingly soluble immunosuppressant-containing o/w emulsion pharmaceutical preparation |
JP2005225818A (en) * | 2004-02-13 | 2005-08-25 | Otsuka Pharmaceut Factory Inc | Medicinal composition of paclitaxel or docetaxel |
JP2007525536A (en) * | 2004-03-01 | 2007-09-06 | エフゲニー パヴロヴィッチ ゲルマノフ | Perfluoro organic compound medical emulsion and its production |
JP2007039430A (en) * | 2005-06-29 | 2007-02-15 | Mitsubishi Chemicals Corp | Particulate dispersion composition, method for producing the same and particulate substance and medicine |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010270023A (en) * | 2009-05-20 | 2010-12-02 | Techno Guard Kk | Nonaqueous composition containing adipose particle holding medicament, and method for producing the same |
FR2962044A1 (en) * | 2010-04-21 | 2012-01-06 | Horus Pharma | LACRYMIMETIC EMULSION |
WO2011131765A3 (en) * | 2010-04-21 | 2012-02-23 | Horus Pharma | Artificial tear emulsion |
US11103490B2 (en) | 2010-10-12 | 2021-08-31 | Chiesi Farmaceutici S.P.A. | Clevidipine emulsion formulations containing antimicrobial agents |
JP2014001203A (en) * | 2012-05-23 | 2014-01-09 | Q P Corp | Method for increasing content of nonsteroidal anti-inflammatory agent in fat emulsion and pharmaceutical composition |
JP2017506671A (en) * | 2014-02-14 | 2017-03-09 | ホアン,ジンジュン | Composition of nanoemulsion delivery system |
JP2014237722A (en) * | 2014-09-19 | 2014-12-18 | ロート製薬株式会社 | Ophthalmic composition for contact lens |
US10413384B2 (en) | 2015-06-29 | 2019-09-17 | Kettenbach Gmbh & Co. Kg | Container for storing and dispensing at least one component and method therefor |
CN106727308A (en) * | 2016-12-14 | 2017-05-31 | 广东药科大学 | A kind of dexamethasone lipid emulsion droplet ocular fluid and preparation method thereof |
JP7456599B2 (en) | 2017-01-12 | 2024-03-27 | テクノガード株式会社 | Drug-containing fat emulsion and its manufacturing method |
CN107441044A (en) * | 2017-08-29 | 2017-12-08 | 辅必成(上海)医药科技有限公司 | A kind of nanometer fat emulsion |
WO2020017571A1 (en) * | 2018-07-18 | 2020-01-23 | テイコク ファーマ ユーエスエー インコーポレーテッド | Flurbiprofen-axetil-containing fat emulsion and method for manufacturing same |
WO2020017578A1 (en) * | 2018-07-18 | 2020-01-23 | テクノガード株式会社 | Oxycam-based drug-containing injection agent |
CN111032033A (en) * | 2018-07-18 | 2020-04-17 | 帝国制药美国公司 | Fat emulsion containing flurbiprofen axetil and method for producing same |
CN112704674A (en) * | 2019-10-25 | 2021-04-27 | 北京远大九和药业有限公司 | Oral emulsion and its prepn and use |
CN112704674B (en) * | 2019-10-25 | 2024-03-12 | 北京远大九和药业有限公司 | A pharmaceutical oral emulsion, and its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
JP5340954B2 (en) | 2013-11-13 |
JPWO2009063962A1 (en) | 2011-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009063962A1 (en) | Fat emulsion containing medicinal agent, and process for production thereof | |
WO2008039737A3 (en) | A method of administering a film product containing a drug | |
WO2009152189A8 (en) | Low dose topiramate/phentermine compostion and methods of use thereof | |
WO2007043057A3 (en) | Compositions for nasal delivery | |
WO2006114520A3 (en) | Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof | |
EP2123257A3 (en) | Stable high Vitamin C content polyol-in-oil emulsified system and its preparation | |
WO2006113631A3 (en) | Bioenhanced compositions | |
MY160074A (en) | Protopanaxadiol-type ginsenoside compositions and uses thereof | |
DK1897558T3 (en) | SOLID PREPARATION OF 2-HEXADECYLOXY-6-METHYL-4H-3,1-BENZOXAZIN-4-ON | |
EA033397B1 (en) | Method of treating prediabetes, type 1 or type 2 diabetes mellitus or improving glycemic control in a patient with said disorders | |
MX2009003542A (en) | Modification of ionic strength in antibody-solutions to reduce opalescence/aggregates. | |
BRPI0922796A2 (en) | PHARMACEUTICAL TABLET FOR ORAL ADMINISTRATION AND MANUFACTURING METHOD | |
WO2008133330A1 (en) | Stable solid preparation comprising 4,5-epoxymorphinan derivative | |
MX2010003603A (en) | Method of treating polycystic kidney diseases with ceramide derivatives. | |
MY160829A (en) | Powdered oil composition and production method thereof, and method of improving the functionality of the oil-in-water emulsion | |
WO2009008656A3 (en) | A soap composition for atopic dermatitis containing fermented extract of xanthium strumarium l. and preparation method thereof | |
IN2015DN02751A (en) | ||
EP1527770A3 (en) | A cosmetic mask composition | |
BR112014013097A2 (en) | Polyolefin foaming method using acrylated epoxidized fatty acid and foam produced from this | |
WO2010095042A3 (en) | Pyridocarbazole type compounds and applications thereof | |
WO2009051217A1 (en) | Fentanyl-containing percutaneous absorption preparation | |
WO2008073764A3 (en) | Substantially pure fluorescein | |
WO2007078848A3 (en) | Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid | |
WO2011019735A3 (en) | Nutritional supplements | |
CN102038029A (en) | Hairtail preservative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08850049 Country of ref document: EP Kind code of ref document: A1 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2009541177 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08850049 Country of ref document: EP Kind code of ref document: A1 |